Articles by Louis-Philippe de Lorimier, DVM, DACVIM (oncology) - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


Articles by Louis-Philippe de Lorimier, DVM, DACVIM (oncology)

Louis-Philippe de Lorimier, DVM, DACVIM (oncology)

Hôpital Vétérinaire Rive-Sud
7415 Boulevard Taschereau
Brossard (Québec) J4Y 1A2, Canada

CVC Highlight: Alleviating cancer pain: A case study
December 1, 2009

Certain cases of cancer may respond well to conservative analgesic therapy initially but eventually require multimodal analgesia.

Treating paraneoplastic hypercalcemia in dogs and cats
May 1, 2007

About 45% to 65% of hypercalcemic dogs and 10% to 30% of hypercalcemic cats have underlying neoplasia.

Malignant mammary tumors: Biologic behavior, prognostic factors, and therapeutic approach in cats
June 1, 2006

Mammary tumors are the third most common feline cancer, 1-3 accounting for 10.3% to 12% of all diagnosed tumors.

An update on diagnosing and treating urinary bladder transitional cell carcinoma in dogs
June 1, 2006

Transitional cell carcinoma of the urinary bladder is by far the most common neoplasm of the urinary system in dogs.

Symposium on oncology
June 1, 2006

Cancer remains one of the most common serious ailments of aging pets. However, better diagnostic capabilities and improved therapeutic options now often translate into enhanced quality of life and longer survival.

Primary hepatic and biliary tract tumors in dogs and cats: An overview
June 1, 2006

Metastatic, disseminated, and locally infiltrative cancers, including metastatic carcinoma, melanoma, lymphoma, hemangiosarcoma, and histiocytic sarcoma, can often affect the hepatic parenchyma.

Treating cancer pain in dogs and cats
May 1, 2005

Recent publications, ongoing prospective studies, and better knowledge of the available therapeutic options should provide the necessary framework for appropriate pain management in cancer-bearing pets.

Understanding and recognizing cancer pain in dogs and cats
May 1, 2005

Pain negatively affects quality of life as well as many important physiological functions, so controlling it in all patients should be a top priority.

Treatment options for canine cutaneous mast cell tumors
April 1, 2005

Because you will likely encounter canine cutaneous mast cell tumors in your practice, this review article focuses on summarizing the therapeutic options available for treating canine mast cell tumors. With a better understanding of available treatment regimens, you will be able to educate and guide pet owners regarding the treatment options that may best suit their dogs.


Click here